{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:48:57Z","timestamp":1791568137481,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jid.2016.03.023","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T17:58:36Z","timestamp":1459447116000},"page":"1387-1397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":333,"title":["Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults"],"prefix":"10.1016","volume":"136","author":[{"given":"Derek Y.","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Brieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette B.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.03.023_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.patbio.2015.05.001","article-title":"Lupus \u00e9ryth\u00e9mateux syst\u00e9mique se pr\u00e9sentant comme un syndrome de Stevens-Johnson [Systemic lupus erythematosus presenting as Stevens-Johnson syndrome]","volume":"63","author":"Bellakhal","year":"2015","journal-title":"Pathologie-biologie"},{"key":"10.1016\/j.jid.2016.03.023_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.jid.2016.03.023_bib4","unstructured":"Centers for Disease Control and Prevention. 2013 NCHS urban\u2013rural classification scheme for counties, http:\/\/www.cdc.gov\/nchs\/data_access\/urban_rural.htm; 2013 (accessed 1 November 2015)."},{"key":"10.1016\/j.jid.2016.03.023_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"(2004) Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jid.2016.03.023_bib7","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1136\/annrheumdis-2014-205577","article-title":"Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin","volume":"74","author":"Chung","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2016.03.023_bib8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/pds.3778","article-title":"Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases","volume":"24","author":"Davis","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jid.2016.03.023_bib9","first-page":"269","article-title":"Toxic epidermal necrolysis and Steven-Johnson syndrome in oncologic patients","volume":"11","author":"Gravante","year":"2007","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jid.2016.03.023_bib10","unstructured":"Healthcare Cost and Utilization Project. Chronic Condition Indicator (CCI) for ICD-9-CM, http:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/chronic\/chronic.jsp; 2016 (accessed 1 November 2015)."},{"key":"10.1016\/j.jid.2016.03.023_bib11","unstructured":"HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD, www.hcup-us.ahrq.gov\/nisoverview.jsp; 2009\u20132012 (accessed November 1, 2015)."},{"key":"10.1016\/j.jid.2016.03.023_bib12","article-title":"Costs of care for hospitalization for pemphigus in the United States","author":"Hsu","year":"2016","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.14463","article-title":"Comorbidities and inpatient mortality for pemphigus in the United States","author":"Hsu","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000195632","article-title":"Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"29","author":"Hung","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jid.2016.03.023_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1377\/hlthaff.20.6.267","article-title":"Out-of-pocket medical spending for care of chronic conditions","volume":"20","author":"Hwang","year":"2001","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jid.2016.03.023_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.BCR.0000216532.71360.9B","article-title":"SCORTEN overestimates mortality in the setting of a standardized treatment protocol","volume":"27","author":"Imahara","year":"2006","journal-title":"J\u00a0Burn Care Res"},{"key":"10.1016\/j.jid.2016.03.023_bib17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/cas.12116","article-title":"Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia\/lymphoma","volume":"104","author":"Ishida","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jid.2016.03.023_bib18","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.4103\/0366-6999.167373","article-title":"Stevens-Johnson Syndrome and hypothermia associated with anti-tuberculosis medication in a patient with heart failure","volume":"128","author":"Jung","year":"2015","journal-title":"Chinese Med J"},{"key":"10.1016\/j.jid.2016.03.023_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000353584","article-title":"Linear IgA bullous disease presenting as toxic\u00a0epidermal necrolysis: a case report and review of the literature","volume":"227","author":"Kakar","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2016.03.023_bib20","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jid.2016.03.023_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3904\/kjim.2012.27.2.203","article-title":"Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients","volume":"27","author":"Kim","year":"2012","journal-title":"Korean J Int Med"},{"key":"10.1016\/j.jid.2016.03.023_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0961203310385162","article-title":"Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases","volume":"20","author":"Lee","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jid.2016.03.023_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1081-1206(10)61112-X","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature","volume":"94","author":"Letko","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jid.2016.03.023_bib24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.burns.2014.02.006","article-title":"A\u00a0systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres","volume":"40","author":"Mahar","year":"2014","journal-title":"Burns"},{"key":"10.1016\/j.jid.2016.03.023_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1067\/mjd.2001.101885","article-title":"Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine","volume":"44","author":"Metry","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11593240-000000000-00000","article-title":"Incidence of toxic epidermal necrolysis and Stevens-Johnson syndrome in an HIV cohort: an observational, retrospective case series study","volume":"13","author":"Mittmann","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of\u00a0medication risks with emphasis on recently marketed drugs. The EuroSCAR-Study","volume":"128","author":"Mockenhaupt","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0310057X0703500317","article-title":"Mycoplasma pneumoniae associated with Stevens Johnson syndrome","volume":"35","author":"Mulvey","year":"2007","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jid.2016.03.023_bib29","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/archderm.1990.01670320127028","article-title":"Incidence of toxic epidermal necrolysis in Italy","volume":"126","author":"Naldi","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib30","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/jdv.13352","article-title":"Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study","volume":"29","author":"Oen","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2016.03.023_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A\u00a0multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J\u00a0Burn Care Rehabil"},{"key":"10.1016\/j.jid.2016.03.023_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/CAD.0000000000000032","article-title":"Life-threatening dermatologic adverse events in oncology","volume":"25","author":"Rosen","year":"2014","journal-title":"Anti-cancer Drug"},{"key":"10.1016\/j.jid.2016.03.023_bib33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","article-title":"(1990b) Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985","volume":"126","author":"Roujeau","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jid.2016.03.023_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and\u00a0toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archderm.1991.01680050083008","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany","volume":"127","author":"Schopf","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib38","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archderm.1991.01680050075007","article-title":"A\u00a0population-based study of Stevens-Johnson syndrome: Incidence and antecedent drug exposures","volume":"127","author":"Strom","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0190-9622(96)90732-X","article-title":"Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme (von Hebra)","volume":"35","author":"Tay","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2011.10.012","article-title":"Erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis associated with lupus erythematosus","volume":"67","author":"Torchia","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.03.023_bib44","unstructured":"United States Census Bureau. CPS Data on Age and Sex, https:\/\/www.census.gov\/population\/age\/data\/cps.html; 2013 (accessed November 1, 2015)."},{"key":"10.1016\/j.jid.2016.03.023_bib42","unstructured":"United States Department of Labor. Consumer price index, http:\/\/www.bls.gov\/cpi\/; 2014 (accessed 1 November 2015)."},{"key":"10.1016\/j.jid.2016.03.023_bib43","first-page":"64","article-title":"Stevens-Johnson syndrome during anti-tuberculosis chemotherapy in HIV-seropositive patients: report on six cases","volume":"68","author":"Wirima","year":"1991","journal-title":"East Afr Med J"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16310120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16310120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T07:43:49Z","timestamp":1718437429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X16310120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0022202X16310120"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.03.023","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}